世界の胃炎治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gastritis Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2490 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、胃炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（酸遮断薬、抗生物質、制酸剤、ヒスタミン遮断薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・胃炎治療の市場動向 ・企業の競争状況、市場シェア ・胃炎治療の種類別市場規模（酸遮断薬、抗生物質、制酸剤、ヒスタミン遮断薬、その他） ・胃炎治療の用途別市場規模（病院、クリニック、その他） ・胃炎治療の北米市場規模2016-2027（アメリカ、カナダ） ・胃炎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・胃炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・胃炎治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・胃炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、AstraZeneca、Novartis、Cipla、Abbott Laboratories、Microbiotix、Reddy's Laboratories、Lupin Ltd、Perrigo Pharmaceutical、Sun Pharmaceutical Industries） ・結論

Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Other possible symptoms include nausea and vomiting, bloating, loss of appetite and heartburn. Complications may include bleeding, stomach ulcers, and stomach tumors.
The Americas is going to account for the largest share for gastritis treatment market. Drivers such as widespread of fast food chains in this region along with the increasing sedentary life culture which in turn contributes to increasing patient pool of gastritis and rising geriatric population are likely to enhance the growth of gastritis treatment market.

Market Analysis and Insights: Global Gastritis Therapeutics Market
The global Gastritis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gastritis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gastritis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gastritis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gastritis Therapeutics market.

Global Gastritis Therapeutics Scope and Market Size
Gastritis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastritis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Acid-Blocking Medicines
Antibiotics
Antacids
Histamine Blockers
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
AstraZeneca
Novartis
Cipla
Abbott Laboratories
Microbiotix
Reddy’s Laboratories
Lupin Ltd
Perrigo Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastritis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acid-Blocking Medicines
1.2.3 Antibiotics
1.2.4 Antacids
1.2.5 Histamine Blockers
1.2.6 Others
1.3 Market by Application
1.3.1 Global Gastritis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gastritis Therapeutics Market Perspective (2016-2027)
2.2 Gastritis Therapeutics Growth Trends by Regions
2.2.1 Gastritis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gastritis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Gastritis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Gastritis Therapeutics Industry Dynamic
2.3.1 Gastritis Therapeutics Market Trends
2.3.2 Gastritis Therapeutics Market Drivers
2.3.3 Gastritis Therapeutics Market Challenges
2.3.4 Gastritis Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gastritis Therapeutics Players by Revenue
3.1.1 Global Top Gastritis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Gastritis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Gastritis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gastritis Therapeutics Revenue
3.4 Global Gastritis Therapeutics Market Concentration Ratio
3.4.1 Global Gastritis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastritis Therapeutics Revenue in 2020
3.5 Gastritis Therapeutics Key Players Head office and Area Served
3.6 Key Players Gastritis Therapeutics Product Solution and Service
3.7 Date of Enter into Gastritis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gastritis Therapeutics Breakdown Data by Type
4.1 Global Gastritis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Gastritis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Gastritis Therapeutics Breakdown Data by Application
5.1 Global Gastritis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Gastritis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gastritis Therapeutics Market Size (2016-2027)
6.2 North America Gastritis Therapeutics Market Size by Type
6.2.1 North America Gastritis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Gastritis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Gastritis Therapeutics Market Size by Type (2016-2027)
6.3 North America Gastritis Therapeutics Market Size by Application
6.3.1 North America Gastritis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Gastritis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Gastritis Therapeutics Market Size by Application (2016-2027)
6.4 North America Gastritis Therapeutics Market Size by Country
6.4.1 North America Gastritis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Gastritis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Gastritis Therapeutics Market Size (2016-2027)
7.2 Europe Gastritis Therapeutics Market Size by Type
7.2.1 Europe Gastritis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Gastritis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Gastritis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Gastritis Therapeutics Market Size by Application
7.3.1 Europe Gastritis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Gastritis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Gastritis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Gastritis Therapeutics Market Size by Country
7.4.1 Europe Gastritis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Gastritis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gastritis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Gastritis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Gastritis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gastritis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gastritis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Gastritis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Gastritis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gastritis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gastritis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Gastritis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Gastritis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gastritis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gastritis Therapeutics Market Size (2016-2027)
9.2 Latin America Gastritis Therapeutics Market Size by Type
9.2.1 Latin America Gastritis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Gastritis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Gastritis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Gastritis Therapeutics Market Size by Application
9.3.1 Latin America Gastritis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Gastritis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Gastritis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Gastritis Therapeutics Market Size by Country
9.4.1 Latin America Gastritis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Gastritis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gastritis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Gastritis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Gastritis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gastritis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gastritis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Gastritis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Gastritis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gastritis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gastritis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Gastritis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Gastritis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gastritis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Gastritis Therapeutics Introduction
11.1.4 Pfizer Revenue in Gastritis Therapeutics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Gastritis Therapeutics Introduction
11.2.4 AstraZeneca Revenue in Gastritis Therapeutics Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Gastritis Therapeutics Introduction
11.3.4 Novartis Revenue in Gastritis Therapeutics Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Cipla
11.4.1 Cipla Company Details
11.4.2 Cipla Business Overview
11.4.3 Cipla Gastritis Therapeutics Introduction
11.4.4 Cipla Revenue in Gastritis Therapeutics Business (2016-2021)
11.4.5 Cipla Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Gastritis Therapeutics Introduction
11.5.4 Abbott Laboratories Revenue in Gastritis Therapeutics Business (2016-2021)
11.5.5 Abbott Laboratories Recent Development
11.6 Microbiotix
11.6.1 Microbiotix Company Details
11.6.2 Microbiotix Business Overview
11.6.3 Microbiotix Gastritis Therapeutics Introduction
11.6.4 Microbiotix Revenue in Gastritis Therapeutics Business (2016-2021)
11.6.5 Microbiotix Recent Development
11.7 Reddy’s Laboratories
11.7.1 Reddy’s Laboratories Company Details
11.7.2 Reddy’s Laboratories Business Overview
11.7.3 Reddy’s Laboratories Gastritis Therapeutics Introduction
11.7.4 Reddy’s Laboratories Revenue in Gastritis Therapeutics Business (2016-2021)
11.7.5 Reddy’s Laboratories Recent Development
11.8 Lupin Ltd
11.8.1 Lupin Ltd Company Details
11.8.2 Lupin Ltd Business Overview
11.8.3 Lupin Ltd Gastritis Therapeutics Introduction
11.8.4 Lupin Ltd Revenue in Gastritis Therapeutics Business (2016-2021)
11.8.5 Lupin Ltd Recent Development
11.9 Perrigo Pharmaceutical
11.9.1 Perrigo Pharmaceutical Company Details
11.9.2 Perrigo Pharmaceutical Business Overview
11.9.3 Perrigo Pharmaceutical Gastritis Therapeutics Introduction
11.9.4 Perrigo Pharmaceutical Revenue in Gastritis Therapeutics Business (2016-2021)
11.9.5 Perrigo Pharmaceutical Recent Development
11.10 Sun Pharmaceutical Industries
11.10.1 Sun Pharmaceutical Industries Company Details
11.10.2 Sun Pharmaceutical Industries Business Overview
11.10.3 Sun Pharmaceutical Industries Gastritis Therapeutics Introduction
11.10.4 Sun Pharmaceutical Industries Revenue in Gastritis Therapeutics Business (2016-2021)
11.10.5 Sun Pharmaceutical Industries Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gastritis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Acid-Blocking Medicines
Table 3. Key Players of Antibiotics
Table 4. Key Players of Antacids
Table 5. Key Players of Histamine Blockers
Table 6. Key Players of Others
Table 7. Global Gastritis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Gastritis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Gastritis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Gastritis Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Gastritis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Gastritis Therapeutics Market Share by Regions (2022-2027)
Table 13. Gastritis Therapeutics Market Trends
Table 14. Gastritis Therapeutics Market Drivers
Table 15. Gastritis Therapeutics Market Challenges
Table 16. Gastritis Therapeutics Market Restraints
Table 17. Global Gastritis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Gastritis Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Gastritis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastritis Therapeutics as of 2020)
Table 20. Ranking of Global Top Gastritis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Gastritis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Gastritis Therapeutics Product Solution and Service
Table 24. Date of Enter into Gastritis Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gastritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Gastritis Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Gastritis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Gastritis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Gastritis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Gastritis Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Gastritis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Gastritis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Gastritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Gastritis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Gastritis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Gastritis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Gastritis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Gastritis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Gastritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Gastritis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Gastritis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Gastritis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Gastritis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Gastritis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Gastritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Gastritis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Gastritis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Gastritis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Gastritis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Gastritis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Gastritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Gastritis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Gastritis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Gastritis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Gastritis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Gastritis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Gastritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Gastritis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Gastritis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Gastritis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Gastritis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Gastritis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Gastritis Therapeutics Product
Table 67. Pfizer Revenue in Gastritis Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. AstraZeneca Company Details
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca Gastritis Therapeutics Product
Table 72. AstraZeneca Revenue in Gastritis Therapeutics Business (2016-2021) & (US$ Million)
Table 73. AstraZeneca Recent Development
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Gastritis Therapeutics Product
Table 77. Novartis Revenue in Gastritis Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. Cipla Company Details
Table 80. Cipla Business Overview
Table 81. Cipla Gastritis Therapeutics Product
Table 82. Cipla Revenue in Gastritis Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Cipla Recent Development
Table 84. Abbott Laboratories Company Details
Table 85. Abbott Laboratories Business Overview
Table 86. Abbott Laboratories Gastritis Therapeutics Product
Table 87. Abbott Laboratories Revenue in Gastritis Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Abbott Laboratories Recent Development
Table 89. Microbiotix Company Details
Table 90. Microbiotix Business Overview
Table 91. Microbiotix Gastritis Therapeutics Product
Table 92. Microbiotix Revenue in Gastritis Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Microbiotix Recent Development
Table 94. Reddy's Laboratories Company Details
Table 95. Reddy's Laboratories Business Overview
Table 96. Reddy's Laboratories Gastritis Therapeutics Product
Table 97. Reddy's Laboratories Revenue in Gastritis Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Reddy's Laboratories Recent Development
Table 99. Lupin Ltd Company Details
Table 100. Lupin Ltd Business Overview
Table 101. Lupin Ltd Revenue in Gastritis Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Lupin Ltd Recent Development
Table 103. Perrigo Pharmaceutical Company Details
Table 104. Perrigo Pharmaceutical Business Overview
Table 105. Perrigo Pharmaceutical Gastritis Therapeutics Product
Table 106. Perrigo Pharmaceutical Revenue in Gastritis Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Perrigo Pharmaceutical Recent Development
Table 108. Sun Pharmaceutical Industries Company Details
Table 109. Sun Pharmaceutical Industries Business Overview
Table 110. Sun Pharmaceutical Industries Gastritis Therapeutics Product
Table 111. Sun Pharmaceutical Industries Revenue in Gastritis Therapeutics Business (2016-2021) & (US$ Million)
Table 112. Sun Pharmaceutical Industries Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastritis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Acid-Blocking Medicines Features
Figure 3. Antibiotics Features
Figure 4. Antacids Features
Figure 5. Histamine Blockers Features
Figure 6. Others Features
Figure 7. Global Gastritis Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Gastritis Therapeutics Report Years Considered
Figure 12. Global Gastritis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Gastritis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Gastritis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Gastritis Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Gastritis Therapeutics Market Share by Players in 2020
Figure 17. Global Top Gastritis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastritis Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Gastritis Therapeutics Revenue in 2020
Figure 19. Global Gastritis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Gastritis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Gastritis Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Gastritis Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Gastritis Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Gastritis Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Gastritis Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Gastritis Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Gastritis Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Gastritis Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Gastritis Therapeutics Market Share by Region (2016-2027)
Figure 41. China Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Gastritis Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Gastritis Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Gastritis Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Gastritis Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Gastritis Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Gastritis Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Gastritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Gastritis Therapeutics Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Gastritis Therapeutics Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Gastritis Therapeutics Business (2016-2021)
Figure 63. Cipla Revenue Growth Rate in Gastritis Therapeutics Business (2016-2021)
Figure 64. Abbott Laboratories Revenue Growth Rate in Gastritis Therapeutics Business (2016-2021)
Figure 65. Microbiotix Revenue Growth Rate in Gastritis Therapeutics Business (2016-2021)
Figure 66. Reddy's Laboratories Revenue Growth Rate in Gastritis Therapeutics Business (2016-2021)
Figure 67. Lupin Ltd Revenue Growth Rate in Gastritis Therapeutics Business (2016-2021)
Figure 68. Perrigo Pharmaceutical Revenue Growth Rate in Gastritis Therapeutics Business (2016-2021)
Figure 69. Sun Pharmaceutical Industries Revenue Growth Rate in Gastritis Therapeutics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---